We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Nalmefene in alcohol‐dependent patients with a high drinking risk: A limited efficacy in reducing alcohol consumption.
- Authors
Palpacuer, Clément; Braillon, Alain; Naudet, Florian
- Abstract
Nalmefene in alcohol-dependent patients with a high drinking risk: A limited efficacy in reducing alcohol consumption Nalmefene authorization in Europe for reducing alcohol consumption in alcohol-dependent patients with high or very high drinking risk level and maintaining a high drinking risk level 2 weeks after initial assessment was granted on the grounds of controversial data. Pharmacologically controlled drinking in the treatment of alcohol dependence or alcohol use disorders: A systematic review with direct and network meta-analyses on nalmefene, naltrexone, acamprosate, baclofen and topiramate.
- Subjects
ALCOHOL drinking; ALCOHOL Dependence Scale; ALCOHOLISM; MEDICAL care; DRUG addiction
- Publication
Psychiatry & Clinical Neurosciences, 2020, Vol 74, Issue 3, p218
- ISSN
1323-1316
- Publication type
Article
- DOI
10.1111/pcn.12946